These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 10841577)

  • 1. Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice.
    Capsoni S; Ugolini G; Comparini A; Ruberti F; Berardi N; Cattaneo A
    Proc Natl Acad Sci U S A; 2000 Jun; 97(12):6826-31. PubMed ID: 10841577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral neutralization of nerve growth factor induces immunosympathectomy and central neurodegeneration in transgenic mice.
    Capsoni S; Tiveron C; Amato G; Vignone D; Cattaneo A
    J Alzheimers Dis; 2010; 20(2):527-46. PubMed ID: 20182028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual mechanism linking NGF/proNGF imbalance and early inflammation to Alzheimer's disease neurodegeneration in the AD11 anti-NGF mouse model.
    Capsoni S; Brandi R; Arisi I; D'Onofrio M; Cattaneo A
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):635-47. PubMed ID: 21631402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice.
    Capsoni S; Giannotta S; Cattaneo A
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12432-7. PubMed ID: 12205295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the molecular basis linking Nerve Growth Factor (NGF) to Alzheimer's disease.
    Capsoni S; Cattaneo A
    Cell Mol Neurobiol; 2006; 26(4-6):619-33. PubMed ID: 16944323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice.
    Pesavento E; Capsoni S; Domenici L; Cattaneo A
    Eur J Neurosci; 2002 Mar; 15(6):1030-6. PubMed ID: 11918663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NGF-cholinergic dependency in brain aging, MCI and Alzheimer's disease.
    Cuello AC; Bruno MA; Bell KF
    Curr Alzheimer Res; 2007 Sep; 4(4):351-8. PubMed ID: 17908036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential deregulation of NGF and BDNF neurotrophins in a transgenic rat model of Alzheimer's disease.
    Iulita MF; Bistué Millón MB; Pentz R; Aguilar LF; Do Carmo S; Allard S; Michalski B; Wilson EN; Ducatenzeiler A; Bruno MA; Fahnestock M; Cuello AC
    Neurobiol Dis; 2017 Dec; 108():307-323. PubMed ID: 28865749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice.
    De Rosa R; Garcia AA; Braschi C; Capsoni S; Maffei L; Berardi N; Cattaneo A
    Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3811-6. PubMed ID: 15728733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of NGF to the brain: intranasal versus ocular administration in anti-NGF transgenic mice.
    Capsoni S; Covaceuszach S; Ugolini G; Spirito F; Vignone D; Stefanini B; Amato G; Cattaneo A
    J Alzheimers Dis; 2009; 16(2):371-88. PubMed ID: 19221427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cholinergic system in aging and neuronal degeneration.
    Schliebs R; Arendt T
    Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy.
    Ruberti F; Capsoni S; Comparini A; Di Daniel E; Franzot J; Gonfloni S; Rossi G; Berardi N; Cattaneo A
    J Neurosci; 2000 Apr; 20(7):2589-601. PubMed ID: 10729339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogen-free husbandry conditions alleviate behavioral deficits and neurodegeneration in AD10 anti-NGF mice.
    Tzanoulinou S; Brandi R; Arisi I; D'Onofrio M; Urfer SM; Sandi C; Constam D; Capsoni S
    J Alzheimers Dis; 2014; 38(4):951-64. PubMed ID: 24121965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.
    Mufson EJ; Ikonomovic MD; Styren SD; Counts SE; Wuu J; Leurgans S; Bennett DA; Cochran EJ; DeKosky ST
    Arch Neurol; 2003 Aug; 60(8):1143-8. PubMed ID: 12925373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissecting the role of sortilin receptor signaling in neurodegeneration induced by NGF deprivation.
    Capsoni S; Amato G; Vignone D; Criscuolo C; Nykjaer A; Cattaneo A
    Biochem Biophys Res Commun; 2013 Feb; 431(3):579-85. PubMed ID: 23313508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.
    Eyjolfsdottir H; Eriksdotter M; Linderoth B; Lind G; Juliusson B; Kusk P; Almkvist O; Andreasen N; Blennow K; Ferreira D; Westman E; Nennesmo I; Karami A; Darreh-Shori T; Kadir A; Nordberg A; Sundström E; Wahlund LO; Wall A; Wiberg M; Winblad B; Seiger Å; Wahlberg L; Almqvist P
    Alzheimers Res Ther; 2016 Jul; 8(1):30. PubMed ID: 27389402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early inflammation and immune response mRNAs in the brain of AD11 anti-NGF mice.
    D'Onofrio M; Arisi I; Brandi R; Di Mambro A; Felsani A; Capsoni S; Cattaneo A
    Neurobiol Aging; 2011 Jun; 32(6):1007-22. PubMed ID: 19604602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of tumour necrosis factor alpha in the brain of transgenic mice differentially alters nerve growth factor levels and choline acetyltransferase activity.
    Aloe L; Fiore M; Probert L; Turrini P; Tirassa P
    Cytokine; 1999 Jan; 11(1):45-54. PubMed ID: 10080878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in CSF cholinergic biomarkers in response to cell therapy with NGF in patients with Alzheimer's disease.
    Karami A; Eyjolfsdottir H; Vijayaraghavan S; Lind G; Almqvist P; Kadir A; Linderoth B; Andreasen N; Blennow K; Wall A; Westman E; Ferreira D; Kristoffersen Wiberg M; Wahlund LO; Seiger Å; Nordberg A; Wahlberg L; Darreh-Shori T; Eriksdotter M
    Alzheimers Dement; 2015 Nov; 11(11):1316-28. PubMed ID: 25676388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.